XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
XBiotech暂停风湿病项目,此前II期类风湿关节炎研究未能满足主要终点,数据出现不规律;未来研究持有,待进一步分析结果。
XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
XBiotech暂停风湿病项目,此前II期类风湿关节炎研究未能满足主要终点,数据出现不规律;未来研究持有,待进一步分析结果。